BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21780344)

  • 1. Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report.
    Korkmaz S; Işik U; Korkmaz H
    Turk Psikiyatri Derg; 2011; 22(2):132-3. PubMed ID: 21780344
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine.
    Curtis AR; Richards RW
    Ann Clin Psychiatry; 2007; 19(3):199-200. PubMed ID: 17729023
    [No Abstract]   [Full Text] [Related]  

  • 3. Staying Up at Night: Overlapping Bipolar and Obsessive-Compulsive Disorder Symptoms in an Adolescent with Autism Spectrum Disorder.
    Cawkwell P; Lawler A; Maneta E; Coffey BJ
    J Child Adolesc Psychopharmacol; 2016 Feb; 26(1):74-7. PubMed ID: 26881860
    [No Abstract]   [Full Text] [Related]  

  • 4. Water, water, everywhere, nor any drop to drink: climate change delusion.
    Wolf J; Salo R
    Aust N Z J Psychiatry; 2008 Apr; 42(4):350. PubMed ID: 18330779
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of schizophrenia with obsessive-compulsive features with serotonin reuptake inhibitors.
    Hwang MY; Martin AM; Lindenmayer JP; Stein D; Hollander E
    Am J Psychiatry; 1993 Jul; 150(7):1127. PubMed ID: 8100402
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe Raynaud's phenomenon associated with interferon-beta 1a and fluoxetine].
    De Broucker T; Lhote F
    Ann Med Interne (Paris); 2000 Sep; 151(5):424-5. PubMed ID: 11033481
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.
    Ferren T; Palmes GK; Kaplan SG
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):509-12. PubMed ID: 24024535
    [No Abstract]   [Full Text] [Related]  

  • 8. Obsessive-compulsive symptoms in schizophrenia: prevalence, clinical features and treatment. A literature review.
    Hadi E; Greenberg Y; Sirota P
    World J Biol Psychiatry; 2012 Jan; 13(1):2-13. PubMed ID: 21554025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine-induced obsessive-compulsive disorder.
    Mottard JP; de la Sablonnière JF
    Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of obsessive-compulsive symptoms in schizophrenia with a neuroleptic-selective serotonin reuptake inhibitor combination: two case reports.
    Sewell DD; Lopez WM; Paulsen J; Gilbert P
    J Nerv Ment Dis; 1994 Dec; 182(12):725-7. PubMed ID: 7989921
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic challenges in comorbid obsessive compulsive disorder with substance use.
    Jain S; Gupta T; Nebhinani N; Singhai K; Suthar N
    Asian J Psychiatr; 2018 Jan; 31():127-128. PubMed ID: 29482123
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment outcome of schizophrenia co-morbid with obsessive-compulsive disorder.
    Sayeed Khan MN; Arshad N; Ullah N
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):234-6. PubMed ID: 15228829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clozapine and obsessive-compulsive symptoms in schizophrenia. A case history of one patient].
    Bürgy M
    Nervenarzt; 1999 Jan; 70(1):64-7. PubMed ID: 10087519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms.
    Rodriguez CI; Corcoran C; Simpson HB
    Am J Psychiatry; 2010 Jul; 167(7):754-61. PubMed ID: 20595428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism.
    Yesilkaya UH; Balcioglu YH
    J Clin Psychopharmacol; 2020; 40(4):412-414. PubMed ID: 32433255
    [No Abstract]   [Full Text] [Related]  

  • 16. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach.
    Fontenelle LF; Leite MA
    J Clin Psychiatry; 2008 Jul; 69(7):1186-7. PubMed ID: 18687019
    [No Abstract]   [Full Text] [Related]  

  • 18. Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders.
    De Haan L; Oekeneva A; Van Amelsvoort T; Linszen D
    Eur Psychiatry; 2004 Dec; 19(8):524. PubMed ID: 15589719
    [No Abstract]   [Full Text] [Related]  

  • 19. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2003 Jun; (9):1339-48. PubMed ID: 12967424
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study.
    Veznedaroglu B; Ercan ES; Kayahan B; Varan A; Bayraktar E
    Hum Psychopharmacol; 2003 Dec; 18(8):635-40. PubMed ID: 14696023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.